ACT |
Adoptive cell transfer |
AKT |
protein kinase B |
APCs |
Antigen presenting cells |
ATP |
Adenosine triphosphate |
B-ALL |
B cell acute lymphoblastic leukemia |
Bcl-X(L) |
B-cell lymphoma-extra large |
CAFs |
Cancer-associated fibroblasts |
CAR |
Chimeric antigen receptor |
CAR-M |
Chimeric antigen receptor macrophage |
CAR-Ps |
Chimeric antigen receptors for phagocytosis |
CAT |
Catalase |
CCR |
Chimeric costimulatory receptor |
CLL |
Chronic lymphocytic leukemia |
CRISPR |
Clustered Regularly Interspaced Short Palindromic Repeats |
CRS |
Cytokine release syndrome |
ECM |
Extracellular matrix |
ETBR |
Endothelin B receptor |
FAO |
Fatty acid oxidation |
GLUT1 |
Glucose transporter 1 |
HER2 |
Human epidermal growth factor receptor 2 |
HK |
Hexokinase 2 |
HPSE |
Heparinase |
HSPG |
Heparan sulphate proteoglycans |
ICOS |
Inducible T cell co-stimulator |
IDO |
Indoleamine-2,3-dioxygenase |
IL-10 |
Interleukin 10 |
LBCL |
Large B cell lymphoma |
MDSC |
Myeloid-derived suppressor cells |
MICA |
Major histocompatibility complex class I polypeptide-related sequence A |
NK |
Natural killer |
OXPHOS |
Oxidative phosphorylation |
PD-1 |
Programmed cell death protein 1 |
PD-L1 |
Programmed cell death ligand 1 |
PFK-6 |
phosphofructo-2-kinase |
PGC1-α |
PPAR-gamma coactivator 1-α |
PGE2 |
Prostaglandin E2 |
PI3K |
Phosphoinositide 3-kinase |
PSMA |
Prostate-specific membrane |
ROS |
Reactive oxygen species |
ScFv |
Single chain variable fragment |
TAA |
Tumor-associated antigens |
TCR |
T cell receptor |
TGFβ |
Transforming growth factor beta |
TILs |
Tumor-infiltration lymphocytes |
TME |
Tumor microenvironment |
VEGF |
Vascular endothelial growth factor |